United States Judicial Panel on Multidistrict Litigation October 2, 2013, MDL No. 2472 (In re Loestrin 24 Fe Antitrust Litigation)

TRANSFER ORDER

JOHN G. HEYBURN II, Chairman.

Before the Panel:* Pursuant to 28 U.S.C. § 1407, defendants1 in several pharmaceutical antitrust actions move to centralize this litigation in the District of New Jersey. This litigation currently consists of four actions pending in the Eastern District of Pennsylvania and two actions pending in the District of Rhode Island, as listed on Schedule A.